CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C30904 | BRD-K89696951 | BRD-K89696951 | -- | -- | -- | Details |
| C30905 | BRD-K89697623 | BRD-K89697623 | -- | -- | -- | Details |
| C30906 | BRD-K89697867 | BRD-K89697867 | -- | -- | -- | Details |
| C30907 | BRD-K89699317 | BRD-K89699317 | -- | -- | -- | Details |
| C30908 | BRD-K89701103 | BRD-K89701103 | -- | -- | -- | Details |
| C30909 | BRD-K89704198 | vincamine | -- | -- | -- | Details |
| C30910 | BRD-K89708791 | rifaximin | NR1I2 | RNA synthesis inhibitor | -- | Details |
| C30911 | BRD-K89712338 | BRD-K89712338 | -- | -- | -- | Details |
| C30912 | BRD-K89715659 | BRD-K89715659 | -- | -- | -- | Details |
| C30913 | BRD-K89719122 | BRD-K89719122 | -- | -- | -- | Details |
| C30914 | BRD-K89724519 | BRD-K89724519 | -- | -- | -- | Details |
| C30915 | BRD-K89732114 | trifluoperazine | DRD2 | Dopamine receptor antagonist | -- | Details |
| C30916 | BRD-K89735991 | BRD-K89735991 | -- | -- | -- | Details |
| C30917 | BRD-K89742282 | BRD-K89742282 | -- | -- | -- | Details |
| C30918 | BRD-K89744662 | BRD-K89744662 | -- | -- | -- | Details |
| C30919 | BRD-K89748417 | BRD-K89748417 | -- | -- | -- | Details |
| C30920 | BRD-K89748981 | BRD-K89748981 | -- | -- | -- | Details |
| C30921 | BRD-K89760040 | BRD-K89760040 | -- | -- | -- | Details |
| C30922 | BRD-K89767945 | BRD-K89767945 | -- | -- | -- | Details |
| C30923 | BRD-K89770910 | BRD-K89770910 | -- | -- | -- | Details |
| C30924 | BRD-K89784888 | BRD-K89784888 | -- | -- | -- | Details |
| C30925 | BRD-K89786160 | BRD-K89786160 | -- | -- | -- | Details |
| C30926 | BRD-K89789047 | beta-testosterone | -- | -- | -- | Details |
| C30927 | BRD-K89793018 | BRD-K89793018 | -- | -- | -- | Details |
| C30928 | BRD-K89793492 | BRD-K89793492 | -- | -- | -- | Details |
| C30929 | BRD-K89796490 | BRD-K89796490 | -- | -- | -- | Details |
| C30930 | BRD-K89801405 | BRD-K89801405 | -- | -- | -- | Details |
| C30931 | BRD-K89801935 | BRD-K89801935 | -- | -- | -- | Details |
| C30932 | BRD-K89805341 | BRD-K89805341 | -- | -- | -- | Details |
| C30933 | BRD-K89805365 | BRD-K89805365 | -- | -- | -- | Details |
| C30934 | BRD-K89806367 | BRD-K89806367 | -- | -- | -- | Details |
| C30935 | BRD-K89808696 | BRD-K89808696 | -- | -- | -- | Details |
| C30936 | BRD-K89811208 | BRD-K89811208 | -- | -- | -- | Details |
| C30937 | BRD-K89814851 | BRD-K89814851 | -- | -- | -- | Details |
| C30938 | BRD-K89820077 | BRD-K89820077 | -- | -- | -- | Details |
| C30939 | BRD-K89824424 | BRD-K89824424 | -- | -- | -- | Details |
| C30940 | BRD-K89830699 | BRD-K89830699 | -- | -- | -- | Details |
| C30941 | BRD-K89832379 | BRD-K89832379 | -- | -- | -- | Details |
| C30942 | BRD-K89832926 | BRD-K89832926 | -- | -- | -- | Details |
| C30943 | BRD-K89833083 | BRD-K89833083 | -- | -- | -- | Details |
| C30944 | BRD-K89833114 | BRD-K89833114 | -- | -- | -- | Details |
| C30945 | BRD-K89837874 | BRD-K89837874 | -- | -- | -- | Details |
| C30946 | BRD-K89839824 | raltitrexed | TYMS | Thymidylate synthase inhibitor | -- | Details |
| C30947 | BRD-K89840812 | BRD-K89840812 | -- | -- | -- | Details |
| C30948 | BRD-K89843224 | BRD-K89843224 | -- | -- | -- | Details |
| C30949 | BRD-K89853033 | BRD-K89853033 | -- | -- | -- | Details |
| C30950 | BRD-K89853519 | fisetinidol | -- | -- | -- | Details |
| C30951 | BRD-K89860739 | BRD-K89860739 | -- | -- | -- | Details |
| C30952 | BRD-K89863047 | BRD-K89863047 | -- | -- | -- | Details |
| C30953 | BRD-K89885223 | BRD-K89885223 | -- | -- | -- | Details |
| C30954 | BRD-K89891928 | BRD-K89891928 | -- | -- | -- | Details |
| C30955 | BRD-K89895693 | BRD-K89895693 | -- | -- | -- | Details |
| C30956 | BRD-K89896024 | BRD-K89896024 | -- | -- | -- | Details |
| C30957 | BRD-K89900384 | BRD-K89900384 | -- | -- | -- | Details |
| C30958 | BRD-K89912164 | BRD-K89912164 | -- | -- | -- | Details |
| C30959 | BRD-K89915215 | BRD-K89915215 | -- | -- | -- | Details |
| C30960 | BRD-K89915754 | BRD-K89915754 | -- | -- | -- | Details |
| C30961 | BRD-K89917372 | retigabine | KCNQ2; KCNQ3; KCNQ5; KCNQ4 | Potassium channel activator | -- | Details |
| C30962 | BRD-K89920769 | BRD-K89920769 | -- | -- | -- | Details |
| C30963 | BRD-K89923877 | scopolamine | CHRM1; CHRM2; CHRM3; CHRM4 | Acetylcholine receptor antagonist | -- | Details |
| C30964 | BRD-K89923892 | BRD-K89923892 | -- | -- | -- | Details |
| C30965 | BRD-K89930444 | AG-592 | -- | -- | -- | Details |
| C30966 | BRD-K89931949 | BRD-K89931949 | -- | -- | -- | Details |
| C30967 | BRD-K89932793 | BRD-K89932793 | -- | -- | -- | Details |
| C30968 | BRD-K89933563 | BRD-K89933563 | -- | -- | -- | Details |
| C30969 | BRD-K89935890 | BRD-K89935890 | -- | -- | -- | Details |
| C30970 | BRD-K89937207 | isobutyraldehyde | -- | -- | -- | Details |
| C30971 | BRD-K89941546 | BRD-K89941546 | -- | -- | -- | Details |
| C30972 | BRD-K89949395 | BRD-K89949395 | -- | -- | -- | Details |
| C30973 | BRD-K89951364 | BRD-K89951364 | -- | -- | -- | Details |
| C30974 | BRD-K89952634 | BRD-K89952634 | -- | -- | -- | Details |
| C30975 | BRD-K89952884 | BRD-K89952884 | -- | -- | -- | Details |
| C30976 | BRD-K89953543 | BRD-K89953543 | -- | -- | -- | Details |
| C30977 | BRD-K89958315 | BRD-K89958315 | -- | -- | -- | Details |
| C30978 | BRD-K89960068 | BRD-K89960068 | -- | -- | -- | Details |
| C30979 | BRD-K89960860 | BRD-K89960860 | -- | -- | -- | Details |
| C30980 | BRD-K89961851 | BRD-K89961851 | -- | -- | -- | Details |
| C30981 | BRD-K89966732 | BRD-K89966732 | -- | -- | -- | Details |
| C30982 | BRD-K89967940 | BRD-K89967940 | -- | -- | -- | Details |
| C30983 | BRD-K89986699 | SA-1459173 | -- | -- | -- | Details |
| C30984 | BRD-K89992188 | BRD-K89992188 | -- | -- | -- | Details |
| C30985 | BRD-K89994146 | BRD-K89994146 | -- | -- | -- | Details |
| C30986 | BRD-K89995901 | BRD-K89995901 | -- | -- | -- | Details |
| C30987 | BRD-K89997465 | BRD-K89997465 | -- | -- | chlorpromazine | Details |
| C30988 | BRD-K89998644 | BRD-K89998644 | -- | -- | -- | Details |
| C30989 | BRD-K90003650 | BRD-K90003650 | -- | -- | -- | Details |
| C30990 | BRD-K90004018 | BRD-K90004018 | -- | -- | -- | Details |
| C30991 | BRD-K90004145 | BRD-K90004145 | -- | -- | -- | Details |
| C30992 | BRD-K90004516 | BRD-K90004516 | -- | -- | -- | Details |
| C30993 | BRD-K90004840 | BRD-K90004840 | -- | -- | -- | Details |
| C30994 | BRD-K90008192 | BRD-K90008192 | -- | -- | -- | Details |
| C30995 | BRD-K90019187 | BRD-K90019187 | -- | -- | -- | Details |
| C30996 | BRD-K90020478 | BRD-K90020478 | -- | -- | -- | Details |
| C30997 | BRD-K90020768 | DAC-013 | -- | -- | -- | Details |
| C30998 | BRD-K90027355 | spironolactone | NR3C2 | Mineralocorticoid receptor antagonist | -- | Details |
| C30999 | BRD-K90027990 | BRD-K90027990 | -- | -- | -- | Details |
| C31000 | BRD-K90028787 | BRD-K90028787 | -- | -- | -- | Details |
| C31001 | BRD-K90040724 | BRD-K90040724 | -- | -- | -- | Details |
| C31002 | BRD-K90041565 | BRD-K90041565 | -- | -- | -- | Details |
| C31003 | BRD-K90041947 | BRD-K90041947 | -- | -- | -- | Details |